Searchable abstracts of presentations at key conferences in endocrinology

ea0094p250 | Neuroendocrinology and Pituitary | SFEBES2023

Hypophysitis secondary to monoclonal antibody treatment

Anand Viswesh , T Srinivasan Balasubramanian

Background: Immunotherapy has become one of the standard interventions to treat various malignancies and auto-immune conditions with favourable responses to the treatment. However, the immune related adverse events of these medications are diverse which may include a variety of endocrinopathies, like Hypo cortisol, Hypophysitis, hypo and hyperthyroid states.Case report: A 62 year old female with a background of Metastati...

ea0062wc8 | Workshop C: Disorders of the thyroid gland | EU2019

TSHoma: an elusive finding

Khawaja Saher Sultan , Shagali Hind , Srinivasan Balasubramanian

Introduction: TSHomas are rare pituitary tumors that secrete an abnormal amount of a hormone called thyroid-stimulating hormone (TSH). Alternatively given the name thyrotropinoma, only makes up to 1%–2% of all pituitary adenomas. Patients often remain misdiagnosed for years. Many patients undergo treatments that end up destroying the thyroid gland. This case report is to emphasize the rarity of the condition and the importance of diagnosing it early and accurately to ensu...

ea0059p166 | Obesity & metabolism | SFEBES2018

Evaluating non-face to face (NFTF) contacts for patients with Thyrotoxicosis

Mulla Kaenat , Razvi Yousuf , Srinivasan Balasubramanian Thiagarajan , Neill Katherine O'

Aim: To evaluate the feasibility of non-face to face (NFTF) contact in the follow-up for patients with thyrotoxicosis on carbimazole therapy.Background: While on carbimazole, achievement of a euthyroid state may involve multiple clinic appointments. We hypothesize by conducting these appointments in a NFTF setting, i.e. telephone consultation with trained nurse practitioner supported by an Endocrine consultant; a higher volume of consultations can occur ...

ea0031p236 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Improvement in testosterone post bariatric surgery

Shankaran Vani , Barclay Amanda , Cinnadorai Rajeswaran , Thida Myat , Balasubramanian Srinivasan

Introduction: Obesity is known to be associated with hypogonadotropic hypogonadism. Hypogonadism is an established risk factor for cardio vascular disease and type 2 diabetes mellitus (T2DM). However there is little evidence on improvement in testosterone with bariatric surgery.Aim and methods: To asses changes in testosterone levels after bariatric surgery. Retrospective study on men undergoing bariatric surgery, and data collected pre and post surgery....

ea0028p231 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Improvement in testosterone post bariatric surgery

Rajeswaran Chinnadorai , Stewart Jennifer , Thida Myat , Min AyeAye , Chadha Mehak , Sowdi Poornima , Thiagarajan Srinivasan Balasubramanian

Introduction: Obesity is known to be associated with hypogonadotropic hypogonadism. Hypogonadism is an established risk factor for cardio vascular disease and Type 2 Diabetes Mellitus (T2DM). However there is paucity on the evidence on improvement in testosterone with bariatric surgery. We report two patients with normalisation of testosterone after bariatric surgery.Case Reports: Patient One 69 year old with BMI 40 and T2DM, hypertension, ischaemic hear...